Sandy Spring Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$3.1M Buy
6,391
+1,615
+34% +$783K 0.13% 140
2024
Q4
$1.92M Buy
4,776
+3,621
+314% +$1.46M 0.08% 177
2024
Q3
$537K Buy
1,155
+815
+240% +$379K 0.02% 282
2024
Q2
$159K Buy
340
+37
+12% +$17.3K 0.01% 392
2024
Q1
$127K Buy
303
+105
+53% +$43.9K 0.01% 420
2023
Q4
$80.6K Buy
198
+181
+1,065% +$73.6K ﹤0.01% 479
2023
Q3
$5.91K Hold
17
﹤0.01% 904
2023
Q2
$5.98K Sell
17
-61
-78% -$21.5K ﹤0.01% 933
2023
Q1
$24.6K Buy
78
+71
+1,014% +$22.4K ﹤0.01% 663
2022
Q4
$2.02K Sell
7
-16
-70% -$4.62K ﹤0.01% 1021
2022
Q3
$7K Buy
23
+16
+229% +$4.87K ﹤0.01% 873
2022
Q2
$2K Hold
7
﹤0.01% 1063
2022
Q1
$2K Hold
7
﹤0.01% 1074
2021
Q4
$2K Sell
7
-100
-93% -$28.6K ﹤0.01% 1158
2021
Q3
$19K Hold
107
﹤0.01% 772
2021
Q2
$21K Sell
107
-6
-5% -$1.18K ﹤0.01% 775
2021
Q1
$25K Buy
113
+7
+7% +$1.55K ﹤0.01% 641
2020
Q4
$25K Sell
106
-194
-65% -$45.8K ﹤0.01% 607
2020
Q3
$82K Sell
300
-14
-4% -$3.83K 0.01% 395
2020
Q2
$91K Hold
314
0.01% 374
2020
Q1
$75K Buy
314
+14
+5% +$3.34K 0.01% 380
2019
Q4
$66K Hold
300
﹤0.01% 433
2019
Q3
$51K Hold
300
﹤0.01% 469
2019
Q2
$55K Sell
300
-27
-8% -$4.95K ﹤0.01% 450
2019
Q1
$60K Buy
327
+27
+9% +$4.95K 0.01% 422
2018
Q4
$50K Hold
300
﹤0.01% 450
2018
Q3
$58K Hold
300
﹤0.01% 443
2018
Q2
$51K Sell
300
-46
-13% -$7.82K ﹤0.01% 462
2018
Q1
$56K Buy
346
+300
+652% +$48.6K 0.01% 462
2017
Q4
$7K Buy
+46
New +$7K ﹤0.01% 731
2017
Q1
Sell
-21
Closed -$2K 875
2016
Q4
$2K Buy
+21
New +$2K ﹤0.01% 821
2016
Q3
Sell
-42
Closed -$4K 892
2016
Q2
$4K Hold
42
﹤0.01% 805
2016
Q1
$3K Sell
42
-24
-36% -$1.71K ﹤0.01% 864
2015
Q4
$8K Buy
66
+24
+57% +$2.91K ﹤0.01% 705
2015
Q3
$4K Hold
42
﹤0.01% 816
2015
Q2
$5K Buy
+42
New +$5K ﹤0.01% 813